{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:55:50Z","timestamp":1792090550117,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:00:00Z","timestamp":1683244800000},"content-version":"am","delay-in-days":308,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG025152"],"award-info":[{"award-number":["R01AG025152"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG060975"],"award-info":[{"award-number":["R01AG060975"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG064589"],"award-info":[{"award-number":["R01AG064589"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DA048001"],"award-info":[{"award-number":["R01DA048001"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.jpsychires.2022.04.033","type":"journal-article","created":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T11:25:44Z","timestamp":1651404344000},"page":"299-303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Population-based signals of benzodiazepine drug interactions associated with unintentional traumatic injury"],"prefix":"10.1016","volume":"151","author":[{"given":"Thanh Phuong","family":"Pham Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9267-4496","authenticated-orcid":false,"given":"Samantha E.","family":"Soprano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Hennessy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen M.","family":"Brensinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren B.","family":"Bilker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd A.","family":"Miano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily K.","family":"Acton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie P.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Dublin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Oslin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas J.","family":"Wiebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5092-9657","authenticated-orcid":false,"given":"Charles E.","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jpsychires.2022.04.033_bib1","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/JCP.0b013e31817d5943","article-title":"Fracture risk from psychotropic medications: a population-based analysis","volume":"28","author":"Bolton","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.jpsychires.2022.04.033_bib2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s40268-017-0207-7","article-title":"Benzodiazepines and Z-drugs: an updated review of major adverse outcomes reported on in epidemiologic research","volume":"17","author":"Brandt","year":"2017","journal-title":"Drugs R"},{"issue":"1","key":"10.1016\/j.jpsychires.2022.04.033_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1089\/sur.2013.9999","article-title":"Clinical practice guidelines for antimicrobial prophylaxis in surgery","volume":"14","author":"Bratzler","year":"2013","journal-title":"Surg. Infect."},{"issue":"1","key":"10.1016\/j.jpsychires.2022.04.033_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/00003088-200038010-00003","article-title":"Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition","volume":"38","author":"Dresser","year":"2000","journal-title":"Clin. Pharmacokinet."},{"issue":"11","key":"10.1016\/j.jpsychires.2022.04.033_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.15348","article-title":"Association of receiving multiple, concurrent fracture-associated drugs with hip fracture risk","volume":"2","author":"Emeny","year":"2019","journal-title":"JAMA Netw. Open"},{"issue":"4","key":"10.1016\/j.jpsychires.2022.04.033_bib6","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/FPC.0000000000000270","article-title":"PharmGKB summary: macrolide antibiotic pathway, pharmacokinetics\/pharmacodynamics","volume":"27","author":"Fohner","year":"2017","journal-title":"Pharmacogenetics Genom."},{"issue":"4","key":"10.1016\/j.jpsychires.2022.04.033_bib7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s40471-014-0027-z","article-title":"Misclassification in administrative claims data: quantifying the impact on treatment effect estimates","volume":"1","author":"Funk","year":"2014","journal-title":"Curr Epidemiol Rep"},{"issue":"4","key":"10.1016\/j.jpsychires.2022.04.033_bib8","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1177\/106002809502900402","article-title":"Relationship between the administration of selected medications and falls in hospitalized elderly patients","volume":"29","author":"Gales","year":"1995","journal-title":"Ann. Pharmacother."},{"issue":"6","key":"10.1016\/j.jpsychires.2022.04.033_bib9","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1532-5415.1987.tb01395.x","article-title":"Medications and diagnoses in relation to falls in a long-term care facility","volume":"35","author":"Granek","year":"1987","journal-title":"J. Am. Geriatr. Soc."},{"issue":"1","key":"10.1016\/j.jpsychires.2022.04.033_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/00039896.1994.9934409","article-title":"Empirical-Bayes and semi-Bayes approaches to occupational and environmental hazard surveillance","volume":"49","author":"Greenland","year":"1994","journal-title":"Arch. Environ. Health"},{"issue":"1","key":"10.1016\/j.jpsychires.2022.04.033_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/injuryprev-2015-041616","article-title":"The global burden of injury: incidence, mortality, disability-adjusted life years and time trends from the Global Burden of Disease study 2013","volume":"22","author":"Haagsma","year":"2016","journal-title":"Inj. Prev."},{"issue":"6","key":"10.1016\/j.jpsychires.2022.04.033_bib12","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1097\/01.TA.0000075350.66739.53","article-title":"Elderly trauma inpatients in New York state: 1994-1998","volume":"56","author":"Hannan","year":"2004","journal-title":"J. Trauma"},{"key":"10.1016\/j.jpsychires.2022.04.033_bib13","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0074-7742(08)00022-6","article-title":"Pharmacodynamic and pharmacokinetic interactions of psychotropic drugs with antiepileptic drugs","volume":"83","author":"Kanner","year":"2008","journal-title":"Int. Rev. Neurobiol."},{"issue":"2","key":"10.1016\/j.jpsychires.2022.04.033_bib14","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/cpt.2195","article-title":"Population-based signals of antidepressant drug interactions associated with unintentional traumatic injury","volume":"110","author":"Leonard","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jpsychires.2022.04.033_bib15","doi-asserted-by":"crossref","first-page":"110531","DOI":"10.1016\/j.biopha.2020.110531","article-title":"Screening to identify signals of opioid drug interactions leading to unintentional traumatic injury","volume":"130","author":"Leonard","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.jpsychires.2022.04.033_bib16","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/cpt.1507","article-title":"Clopidogrel drug interactions and serious bleeding: generating real-world evidence via automated high-throughput pharmacoepidemiologic screening","volume":"106","author":"Leonard","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.jpsychires.2022.04.033_bib17","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/00001648-199411000-00006","article-title":"Psychoactive medications and injurious motor vehicle collisions involving older drivers","volume":"5","author":"Leveille","year":"1994","journal-title":"Epidemiology"},{"issue":"2","key":"10.1016\/j.jpsychires.2022.04.033_bib18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1176\/appi.ps.201800321","article-title":"Benzodiazepine use and misuse among adults in the United States","volume":"70","author":"Maust","year":"2019","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.jpsychires.2022.04.033_bib19","series-title":"WISQARS: 10 Leading Causes of Death","year":"2018"},{"key":"10.1016\/j.jpsychires.2022.04.033_bib20","series-title":"WISQARS\u2122 \u2014 Web-Based Injury Statistics Query and Reporting System","year":"2020"},{"issue":"8","key":"10.1016\/j.jpsychires.2022.04.033_bib21","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.4088\/JCP.11m07624","article-title":"Risk of injurious road traffic crash after prescription of antidepressants","volume":"73","author":"Orriols","year":"2012","journal-title":"J. Clin. Psychiatr."},{"issue":"12","key":"10.1016\/j.jpsychires.2022.04.033_bib22","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/JGP.0b013e31820d93f9","article-title":"At-fault motor vehicle crash risk in elderly patients treated with antidepressants","volume":"19","author":"Rapoport","year":"2011","journal-title":"Am. J. Geriatr. Psychiatr."},{"issue":"7","key":"10.1016\/j.jpsychires.2022.04.033_bib23","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/aje\/136.7.873","article-title":"Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers","volume":"136","author":"Ray","year":"1992","journal-title":"Am. J. Epidemiol."},{"issue":"7","key":"10.1016\/j.jpsychires.2022.04.033_bib24","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJM198702123160702","article-title":"Psychotropic drug use and the risk of hip fracture","volume":"316","author":"Ray","year":"1987","journal-title":"N. Engl. J. Med."},{"issue":"37","key":"10.1016\/j.jpsychires.2022.04.033_bib25","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.2174\/1381612823666170809102258","article-title":"Potentially clinically relevant pharmacodynamic interactions between antiepileptic drugs and psychotropic drugs: an update","volume":"23","author":"Spina","year":"2017","journal-title":"Curr. Pharmaceut. Des."},{"issue":"9","key":"10.1016\/j.jpsychires.2022.04.033_bib26","first-page":"895","article-title":"Empirical Bayes adjustments for multiple results in hypothesis-generating or surveillance studies","volume":"9","author":"Steenland","year":"2000","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"2","key":"10.1016\/j.jpsychires.2022.04.033_bib27","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1093\/cid\/ciu296","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.jpsychires.2022.04.033_bib28","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jgs.15767","article-title":"American Geriatrics society 2019 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults","volume":"67","year":"2019","journal-title":"J. Am. Geriatr. Soc."},{"issue":"3","key":"10.1016\/j.jpsychires.2022.04.033_bib29","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/cpt.2350","article-title":"An evidence-based framework for evaluating pharmacogenomics knowledge for personalized medicine","volume":"110","author":"Whirl-Carrillo","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.jpsychires.2022.04.033_bib30","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/cpt.1845","article-title":"Pharmacoepidemiologic screening of potential oral anticoagulant drug interactions leading to thromboembolic events","volume":"108","author":"Zhou","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.jpsychires.2022.04.033_bib31","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/pds.2031","article-title":"Impact of drug interactions, dosage, and duration of therapy on the risk of hip fracture associated with benzodiazepine use in older adults","volume":"19","author":"Zint","year":"2010","journal-title":"Pharmacoepidemiol. Drug Saf."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395622002333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395622002333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:31:04Z","timestamp":1758367864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395622002333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":31,"alternative-id":["S0022395622002333"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2022.04.033","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Population-based signals of benzodiazepine drug interactions associated with unintentional traumatic injury","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2022.04.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}